Si-Wu-Tang has shown efficacy in inhibiting the TLR4-JNK and caspase-8-GSDMD signaling pathways, offering therapeutic benefits for NAFLD (Zhang et al., 2020). The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.